Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vor Biopharma Inc | Sandesh Mahatme | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 13,882,750 | 13,882,750 | - | 0 | Common Stock | |
| Rivian Automotive Inc - Or... | Robert J. Scaringe | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 09 Jul 2025 | 3,914,798 | 2,297 | - | 0 | Class A Common Stock | |
| Rivian Automotive Inc - Or... | Robert J. Scaringe | Director, Chief Executive Officer | 09 Jul 2025 | 3,912,500 | 3,912,500 | - | - | Class B Common Stock | ||
| Rivian Automotive Inc - Or... | Robert J. Scaringe | Director, Chief Executive Officer | 09 Jul 2025 | 3,912,500 | 3,917,095 | - | - | Class A Common Stock | ||
| Rivian Automotive Inc - Or... | Robert J. Scaringe | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 09 Jul 2025 | 3,642,631 | 3,642,631 | - | - | Stock Option | |
| Oracle | Lawrence J. Ellison | Director, Executive Chairman, Ten Percent Owner, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.13 per share. | 09 Jul 2025 | 2,500,000 | 1,148,232,353 (35%) | 0% | 51.1 | 127,825,000 | Common Stock |
| Oracle | Lawrence J. Ellison | Director, Executive Chairman, Ten Percent Owner, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 2,500,000 | 0 | - | - | Stock Option | |
| Oracle | Lawrence J. Ellison | Director, Executive Chairman, Ten Percent Owner, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 2,500,000 | 0 | - | - | Stock Option | |
| Oracle | Lawrence J. Ellison | Director, Executive Chairman, Ten Percent Owner, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.13 per share. | 09 Jul 2025 | 2,500,000 | 1,150,732,353 (35%) | 0% | 51.1 | 127,825,000 | Common Stock |
| Rivian Automotive Inc - Or... | Robert J. Scaringe | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 09 Jul 2025 | 1,863,133 | 25,278,128 | - | - | Stock Option | |
| Oracle | Lawrence J. Ellison | Director, Executive Chairman, Ten Percent Owner, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 1,000,000 | 1,500,000 | - | - | Stock Option | |
| Oracle | Lawrence J. Ellison | Director, Executive Chairman, Ten Percent Owner, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.13 per share. | 09 Jul 2025 | 1,000,000 | 1,151,732,353 (35%) | 0% | 51.1 | 51,130,000 | Common Stock |
| BTCS Inc | Charles W. Allen | Director, CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 750,000 | 0 | - | - | Stock Options (Right to Buy) | |
| BTCS Inc | Charles W. Allen | Director, CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.90 per share. | 09 Jul 2025 | 508,884 | 4,679,506 | - | 1.9 | 966,880 | Common Stock |
| Rivian Automotive Inc - Or... | Robert J. Scaringe | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 09 Jul 2025 | 500,000 | 500,000 | - | - | Stock Option | |
| Denali Therapeutics Inc | Ryan J. Watts | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 09 Jul 2025 | 495,282 | 253,071 (0%) | 0% | 15 | 7,429,230 | Common Stock |
| Denali Therapeutics Inc | Ryan J. Watts | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.68 per share. | 09 Jul 2025 | 455,282 | 708,353 (0%) | 0% | 0.7 | 309,592 | Common Stock |
| Denali Therapeutics Inc | Ryan J. Watts | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 455,282 | 622,809 | - | - | Stock Option (right to buy) | |
| Brown Forman | Campbell P. Brown | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Jul 2025 | 390,000 | 180,863 (0%) | 0% | 0 | Class B Common | |
| Brown Forman | Campbell P. Brown | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Jul 2025 | 390,000 | 390,000 (0%) | 0% | 0 | Class B Common | |
| Heart Test Laboratories Inc | Andrew Simpson | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 275,000 | 275,000 | - | - | Stock Option (Right to Buy) | |
| Mobix Labs Inc - Ordinary ... | David J. Aldrich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 226,677 | 242,889 | - | 0 | Class A Common Stock | |
| Mobix Labs Inc - Ordinary ... | Michael J. Long | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 226,677 | 965,282 | - | 0 | Class A Common Stock | |
| Heart Test Laboratories Inc | Mark T. Hilz | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 225,000 | 225,000 | - | - | Stock Option (Right to Buy) | |
| Mobix Labs Inc - Ordinary ... | Kurt F. Busch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 221,775 | 325,574 | - | 0 | Class A Common Stock | |
| Burford Capital Limited | Christopher P. Bogart | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.60 per share. | 09 Jul 2025 | 210,000 | 278,862 | - | 14.6 | 3,064,950 | Ordinary shares, no par value ("Ordinary Shares") |
| Burford Capital Limited | Christopher P. Bogart | Director and Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.60 per share. | 09 Jul 2025 | 210,000 | 9,622,674 (4%) | 0% | 14.6 | 3,064,971 | Ords |
| Burford Capital Limited | Jonathan Molot | Chief Investment Officer | Sale of securities on an exchange or to another person at price $ 14.60 per share. | 09 Jul 2025 | 210,000 | 3,406,625 | - | 14.6 | 3,064,950 | Ordinary shares, no par value ("Ordinary Shares") |
| AMBAC Financial Group Inc. | Claude L. LeBlanc | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 163,695 | 235,151 | - | - | Restricted Stock Units | |
| Mobix Labs Inc - Ordinary ... | Frederick C. Goerner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 131,356 | 1,436,525 | - | 0 | Class A Common Stock | |
| Carvana Co. - Ordinary Sha... | Ernest C. Garcia | Ten Percent Owner | 09 Jul 2025 | 125,000 | 45,296,681 | - | - | Class A Units | ||
| Carvana Co. - Ordinary Sha... | Ernest C. Garcia | Ten Percent Owner | 09 Jul 2025 | 125,000 | 45,421,681 | - | - | Class A Units | ||
| Photronics, Inc. | George C. Macricostas | CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 109,830 | 277,830 (0%) | 0% | 0 | COMMON STOCK | |
| Carvana Co. - Ordinary Sha... | Ernest C. Garcia | Ten Percent Owner | 09 Jul 2025 | 100,000 | 100,000 (0%) | 0% | - | Class A Common Stock | ||
| Carvana Co. - Ordinary Sha... | Ernest C. Garcia | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 09 Jul 2025 | 100,000 | 36,337,346 (71%) | 0% | - | Class B Common Stock | |
| Carvana Co. - Ordinary Sha... | Ernest C. Garcia | Ten Percent Owner | 09 Jul 2025 | 100,000 | 100,000 (0%) | 0% | - | Class A Common Stock | ||
| Carvana Co. - Ordinary Sha... | Ernest C. Garcia | Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 09 Jul 2025 | 100,000 | 36,237,346 (71%) | 0% | - | Class B Common Stock | |
| Mobix Labs Inc - Ordinary ... | James Aralis | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 100,000 | 128,993 | - | 0 | Class A Common Stock | |
| Hagerty Inc - Ordinary Sha... | Robert I. Kauffman | Director | Sale of securities on an exchange or to another person at price $ 10.07 per share. | 09 Jul 2025 | 98,766 | 3,550,490 | - | 10.1 | 994,574 | Class A Common Stock |
| Salesforce | Marc Benioff | Director, Chair and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 93,109 | 11,955,566 (1%) | 0% | 0 | Common Stock | |
| Rivian Automotive Inc - Or... | Robert J. Scaringe | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 09 Jul 2025 | 88,061 | 1,395,050 | - | 0 | Class A Common Stock | |
| Astera Labs Inc. | Sanjay Gajendra | Director, President and COO | Sale of securities on an exchange or to another person at price $ 98.52 per share. | 09 Jul 2025 | 86,685 | 5,843,860 | - | 98.5 | 8,540,328 | Common Stock |
| Pinterest Inc - Ordinary S... | Benjamin Silbermann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 35.50 per share. | 09 Jul 2025 | 83,333 | 0 (0%) | 0% | 35.5 | 2,958,172 | Class A Common Stock |
| Pinterest Inc - Ordinary S... | Benjamin Silbermann | Director, Ten Percent Owner | 09 Jul 2025 | 83,333 | 36,486,893 | - | - | Class B Common Stock | ||
| Pinterest Inc - Ordinary S... | Benjamin Silbermann | Director, Ten Percent Owner | 09 Jul 2025 | 83,333 | 83,333 (0%) | 0% | 0 | Class A Common Stock | ||
| Village Farms Internationa... | Kathleen M. Mahoney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 75,757 | 75,757 | - | - | Restricted Stock | |
| Village Farms Internationa... | John R. McLernon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 75,757 | 75,757 | - | - | Restricted Stock | |
| Village Farms Internationa... | Christopher Woodward | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 75,757 | 75,757 | - | - | Restricted Stock | |
| Village Farms Internationa... | John Henry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 75,757 | 75,757 | - | - | Restricted Stock | |
| Village Farms Internationa... | David Holewinski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 75,757 | 75,757 | - | - | Restricted Stock | |
| Village Farms Internationa... | Carolyn Hauger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 75,757 | 75,757 | - | - | Restricted Stock | |
| Abeona Therapeutics Inc | Vishwas Seshadri | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 5.86 per share. | 09 Jul 2025 | 69,420 | 1,234,341 (1%) | 0% | 5.9 | 406,503 | Common Stock |
| Heart Test Laboratories Inc | Andrew Simpson | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 68,750 | 68,750 | - | - | Restricted Stock Units | |
| Neurocrine Biosciences, Inc. | Jude Onyia | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 84.74 per share. | 09 Jul 2025 | 59,819 | 78,108 (0%) | 0% | 84.7 | 5,069,062 | Common Stock |
| Neurocrine Biosciences, Inc. | Jude Onyia | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 59,819 | 35,268 | - | - | Non-Qualified Stock Option | |
| Neurocrine Biosciences, Inc. | Jude Onyia | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 130.46 per share. | 09 Jul 2025 | 59,819 | 18,289 (0%) | 0% | 130.5 | 7,803,688 | Common Stock |
| Heart Test Laboratories Inc | Mark T. Hilz | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 56,250 | 56,250 | - | - | Restricted Stock Units | |
| Unity Software Inc | Shlomo Dovrat | Director | Sale of securities on an exchange or to another person at price $ 30.01 per share. | 09 Jul 2025 | 50,000 | 189,089 | - | 30.0 | 1,500,500 | Common Stock |
| Broadcom | Henry Samueli | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Jul 2025 | 49,670 | 31,429,540 (7%) | 0% | 0 | Common Stock, $0.001 par value | |
| Alto Ingredients Inc | Gilbert E. Nathan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 49,166 | 749,741 (1%) | 0% | 0 | Common Stock | |
| LegalZoom.com Inc. | Noel Watson | Chief Operating Officer & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.97 per share. | 09 Jul 2025 | 48,516 | 1,793,097 | - | 9.0 | 435,189 | Common Stock |
| LegalZoom.com Inc. | Nicole Miller | CHIEF LEGAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.97 per share. | 09 Jul 2025 | 48,516 | 1,018,221 | - | 9.0 | 435,189 | Common Stock |
| UiPath Inc - Ordinary Shar... | Daniel Dines | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 13.17 per share. | 09 Jul 2025 | 45,000 | 5,283,376 | - | 13.2 | 592,668 | Class A Common Stock |
| Pegasystems Inc. | Alan Trefler | Director, C.E.O. & Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 53.34 per share. | 09 Jul 2025 | 45,000 | 33,051,692 (41%) | 0% | 53.3 | 2,400,300 | Common stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.57 per share. | 09 Jul 2025 | 42,740 | 783,927 | - | 3.6 | 152,582 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Hunter C. Smith | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.88 per share. | 09 Jul 2025 | 42,120 | 159,035 (0%) | 0% | 6.9 | 289,786 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Hunter C. Smith | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 42,120 | 28,088 | - | - | Stock Options (Right to Buy) | |
| Taboola.com Ltd | Eldad Maniv | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.76 per share. | 09 Jul 2025 | 41,377 | 10,822,821 | - | 3.8 | 155,578 | Ordinary Shares |
| Hagerty Inc - Ordinary Sha... | Robert I. Kauffman | Director | Sale of securities on an exchange or to another person at price $ 10.10 per share. | 09 Jul 2025 | 41,239 | 3,509,251 | - | 10.1 | 416,514 | Class A Common Stock |
| Denali Therapeutics Inc | Ryan J. Watts | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 40,000 | 20,369 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Ryan J. Watts | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.28 per share. | 09 Jul 2025 | 40,000 | 748,353 (0%) | 0% | 5.3 | 211,200 | Common Stock |
| AMBAC Financial Group Inc. | David Trick | Exec VP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 39,586 | 56,920 | - | - | Restricted Stock Units | |
| Astera Labs Inc. | Sanjay Gajendra | Director, President and COO | Sale of securities on an exchange or to another person at price $ 99.21 per share. | 09 Jul 2025 | 38,315 | 5,805,545 | - | 99.2 | 3,801,204 | Common Stock |
| Alto Ingredients Inc | Dianne S. Nury | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 36,666 | 217,410 (0%) | 0% | 0 | Common Stock | |
| Alto Ingredients Inc | Maria G. Gray | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 36,666 | 155,624 (0%) | 0% | 0 | Common Stock | |
| Alto Ingredients Inc | Jeremy T. Bezdek | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 36,666 | 36,666 (0%) | 0% | 0 | Common Stock | |
| Alto Ingredients Inc | Alan R. Tank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 36,666 | 36,666 (0%) | 0% | 0 | Common Stock | |
| Health Catalyst Inc | John A. Kane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 36,231 | 170,719 (0%) | 0% | 0 | Common Stock | |
| Health Catalyst Inc | S. Dawn Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 36,231 | 101,692 (0%) | 0% | 0 | Common Stock | |
| Health Catalyst Inc | Duncan Gallagher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 36,231 | 113,282 (0%) | 0% | 0 | Common Stock | |
| Health Catalyst Inc | Julie Larson-Green | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 36,231 | 111,251 (0%) | 0% | 0 | Common Stock | |
| Health Catalyst Inc | Green Jill Hoggard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 36,231 | 63,937 (0%) | 0% | 0 | Common Stock | |
| AMBAC Financial Group Inc. | R. Sharon Smith | Exec VP & Chief Strategy Offr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 35,307 | 50,767 | - | - | Restricted Stock Units | |
| Disc Medicine Inc | John D. Quisel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 34,800 | 115,375 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | John D. Quisel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.86 per share. | 09 Jul 2025 | 34,800 | 196,628 | - | 9.9 | 343,128 | Common Stock |
| Microstrategy Inc. - Ordin... | W. Ming Shao | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 401.47 per share. | 09 Jul 2025 | 32,500 | 12,726 (0%) | 0% | 401.5 | 13,047,678 | Class A Common Stock |
| AMBAC Financial Group Inc. | Stephen M. Ksenak | Sr. MD & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 32,097 | 46,151 | - | - | Restricted Stock Units | |
| Disc Medicine Inc | John D. Quisel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 55.23 per share. | 09 Jul 2025 | 31,207 | 165,421 | - | 55.2 | 1,723,600 | Common Stock |
| Penumbra Inc | Adam Elsesser | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.00 per share. | 09 Jul 2025 | 27,976 | 150,417 (0%) | 0% | 30 | 839,280 | Common Stock |
| Penumbra Inc | Adam Elsesser | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 27,976 | 111,908 | - | - | Stock Option (right to buy) | |
| Abeona Therapeutics Inc | Joseph W. Vazzano | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.86 per share. | 09 Jul 2025 | 25,411 | 479,168 (0%) | 0% | 5.9 | 148,799 | Common Stock |
| Heart Test Laboratories Inc | David R. Wells | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Heart Test Laboratories Inc | Danielle Watson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Heart Test Laboratories Inc | Bruce Bent | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Heart Test Laboratories Inc | Brian Szymczak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| EchoStar Corp - Ordinary S... | Dean A. Manson | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.04 per share. | 09 Jul 2025 | 25,000 | 27,322 (0%) | 0% | 14.0 | 351,000 | Class A Common Stock |
| EchoStar Corp - Ordinary S... | Dean A. Manson | CHIEF LEGAL OFFICER | Sale of securities on an exchange or to another person at price $ 33.00 per share. | 09 Jul 2025 | 25,000 | 2,322 (0%) | 0% | 33 | 825,000 | Class A Common Stock |
| EchoStar Corp - Ordinary S... | Dean A. Manson | CHIEF LEGAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 25,000 | 107,331 | - | - | Employee Stock Option (Right to Buy) | |
| Rhythm Pharmaceuticals Inc. | Hunter C. Smith | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 84.50 per share. | 09 Jul 2025 | 23,400 | 116,915 (0%) | 0% | 84.5 | 1,977,300 | Common Stock |
| Carvana Co. - Ordinary Sha... | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 350.17 per share. | 09 Jul 2025 | 22,425 | 45,568 (0%) | 0% | 350.2 | 7,852,553 | Class A Common Stock |
| Zoom Video Communications ... | Velchamy Sankarlingam | Pres. of Engineering & Product | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 20,752 | 147,576 (0%) | 0% | 0 | Class A Common Stock | |
| Zoom Video Communications ... | Velchamy Sankarlingam | Pres. of Engineering & Product | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 20,752 | 228,268 | - | - | Restricted Stock Units | |
| Entrada Therapeutics Inc | Kush M. Parmar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.50 per share. | 09 Jul 2025 | 20,065 | 3,163,066 | - | 7.5 | 150,528 | Common Stock |
| Vicor Corp. | Philip Davies | Director, VP Global Sales & Marketing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 20,000 | 20,000 | - | - | Non Qualified Stock Option | |
| Astera Labs Inc. | Sanjay Gajendra | Director, President and COO | Sale of securities on an exchange or to another person at price $ 98.21 per share. | 09 Jul 2025 | 20,000 | 695,000 | - | 98.2 | 1,964,156 | Common Stock |
| Astera Labs Inc. | Sanjay Gajendra | Director, President and COO | Sale of securities on an exchange or to another person at price $ 98.22 per share. | 09 Jul 2025 | 20,000 | 695,000 | - | 98.2 | 1,964,360 | Common Stock |
| Microstrategy Inc. - Ordin... | W. Ming Shao | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 20,000 | 180,000 | - | - | Employee Stock Option (Right to buy) | |
| Microstrategy Inc. - Ordin... | W. Ming Shao | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 20,000 | 160,000 | - | - | Employee Stock Option (Right to buy) | |
| Microstrategy Inc. - Ordin... | W. Ming Shao | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.46 per share. | 09 Jul 2025 | 20,000 | 32,726 (0%) | 0% | 40.5 | 809,200 | Class A Common Stock |
| Microstrategy Inc. - Ordin... | W. Ming Shao | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.46 per share. | 09 Jul 2025 | 20,000 | 32,726 (0%) | 0% | 40.5 | 809,200 | Class A Common Stock |
| Netsol Technologies, Inc. | Najeeb U. Ghauri | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 20,000 | 933,313 (7%) | 0% | 0 | Common Stock | |
| Pinterest Inc - Ordinary S... | Benjamin Silbermann | Director, Ten Percent Owner | 09 Jul 2025 | 18,750 | 18,750 (0%) | 0% | 0 | Class A Common Stock | ||
| Pinterest Inc - Ordinary S... | Benjamin Silbermann | Director, Ten Percent Owner | 09 Jul 2025 | 18,750 | 8,931,280 | - | - | Class B Common Stock | ||
| Pinterest Inc - Ordinary S... | Benjamin Silbermann | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 35.49 per share. | 09 Jul 2025 | 18,750 | 0 (0%) | 0% | 35.5 | 665,498 | Class A Common Stock |
| Relay Therapeutics Inc | Sanjiv K. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.57 per share. | 09 Jul 2025 | 18,639 | 765,288 | - | 3.6 | 66,541 | Common Stock |
| AMBAC Financial Group Inc. | Daniel McGinnis | Sr. MD & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 18,188 | 26,152 | - | - | Restricted Stock Units | |
| Burford Capital Limited | Aviva Will | President | Sale of securities on an exchange or to another person at price $ 14.60 per share. | 09 Jul 2025 | 17,500 | 293,479 | - | 14.6 | 255,413 | Ordinary shares, no par value ("Ordinary Shares") |
| Abeona Therapeutics Inc | Brendan M. O'Malley | SVP, Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 5.86 per share. | 09 Jul 2025 | 17,428 | 360,817 (0%) | 0% | 5.9 | 102,053 | Common Stock |
| Carvana Co. - Ordinary Sha... | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 350.97 per share. | 09 Jul 2025 | 17,126 | 28,442 (0%) | 0% | 351.0 | 6,010,726 | Class A Common Stock |
| Rhythm Pharmaceuticals Inc. | Hunter C. Smith | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 75.38 per share. | 09 Jul 2025 | 17,113 | 141,922 (0%) | 0% | 75.4 | 1,290,050 | Common Stock |
| Merus N.V | Peter B. Silverman | COO & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 16,805 | 0 | - | - | Share Option (right to buy) | |
| Merus N.V | Peter B. Silverman | COO & GC | Sale of securities on an exchange or to another person at price $ 55.00 per share. | 09 Jul 2025 | 16,805 | 0 (0%) | 0% | 55 | 924,275 | Common Shares |
| Merus N.V | Peter B. Silverman | COO & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.61 per share. | 09 Jul 2025 | 16,805 | 16,805 (0%) | 0% | 18.6 | 312,741 | Common Shares |
| Carvana Co. - Ordinary Sha... | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 352.09 per share. | 09 Jul 2025 | 16,211 | 12,231 (0%) | 0% | 352.1 | 5,707,684 | Class A Common Stock |
| Carvana Co. - Ordinary Sha... | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 354.65 per share. | 09 Jul 2025 | 15,916 | 22,080 (0%) | 0% | 354.6 | 5,644,560 | Class A Common Stock |
| Netsol Technologies, Inc. | Najeeb U. Ghauri | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Jul 2025 | 15,000 | 918,313 (7%) | 0% | 0 | Common Stock | |
| Cloudastructure Inc. - Ord... | Richard Bentley | Ten Percent Owner, Founder | Sale of securities on an exchange or to another person at price $ 2.05 per share. | 09 Jul 2025 | 13,526 | 202,195 | - | 2.0 | 27,728 | Class A Common Stock |
| Abeona Therapeutics Inc | Mark J. Alvino | Director | Sale of securities on an exchange or to another person at price $ 5.86 per share. | 09 Jul 2025 | 13,093 | 77,252 (0%) | 0% | 5.9 | 76,669 | Common Stock |
| Abeona Therapeutics Inc | Christine Berni Silverstein | Director | Sale of securities on an exchange or to another person at price $ 5.86 per share. | 09 Jul 2025 | 13,093 | 120,479 (0%) | 0% | 5.9 | 76,669 | Common Stock |
| Carvana Co. - Ordinary Sha... | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 355.57 per share. | 09 Jul 2025 | 12,792 | 9,288 (0%) | 0% | 355.6 | 4,548,472 | Class A Common Stock |
| Microstrategy Inc. - Ordin... | W. Ming Shao | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 12,500 | 100,000 | - | - | Employee Stock Option (Right to buy) | |
| Microstrategy Inc. - Ordin... | W. Ming Shao | EVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.50 per share. | 09 Jul 2025 | 12,500 | 45,226 (0%) | 0% | 17.5 | 218,750 | Class A Common Stock |
| Cloudastructure Inc. - Ord... | Richard Bentley | Ten Percent Owner, Founder | Sale of securities on an exchange or to another person at price $ 2.18 per share. | 09 Jul 2025 | 12,191 | 215,721 | - | 2.2 | 26,576 | Class A Common Stock |
| Agios Pharmaceuticals Inc | Sarah Gheuens | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 11,914 | 32,086 | - | - | Stock options (right to buy) | |
| Agios Pharmaceuticals Inc | Sarah Gheuens | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.01 per share. | 09 Jul 2025 | 11,914 | 73,185 (0%) | 0% | 25.0 | 297,969 | Common stock |
| Carvana Co. - Ordinary Sha... | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 353.14 per share. | 09 Jul 2025 | 11,906 | 325 (0%) | 0% | 353.1 | 4,204,441 | Class A Common Stock |
| Carvana Co. - Ordinary Sha... | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 349.33 per share. | 09 Jul 2025 | 11,813 | 67,993 (0%) | 0% | 349.3 | 4,126,651 | Class A Common Stock |
| Agios Pharmaceuticals Inc | Sarah Gheuens | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 37.93 per share. | 09 Jul 2025 | 11,067 | 62,118 (0%) | 0% | 37.9 | 419,771 | Common stock |
| Abeona Therapeutics Inc | Faith L. Charles | Director | Sale of securities on an exchange or to another person at price $ 5.86 per share. | 09 Jul 2025 | 10,738 | 139,094 (0%) | 0% | 5.9 | 62,879 | Common Stock |
| Hercules Capital Inc | Scott Bluestein | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.56 per share. | 09 Jul 2025 | 10,593 | 2,281,611 (2%) | 0% | 18.6 | 196,606 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.80 per share. | 09 Jul 2025 | 10,547 | 29,756 (0%) | 0% | 6.8 | 71,720 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 10,547 | 17,581 | - | - | Stock Options (Right to Buy) | |
| Zoom Video Communications ... | Velchamy Sankarlingam | Pres. of Engineering & Product | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.42 per share. | 09 Jul 2025 | 10,538 | 137,038 (0%) | 0% | 77.4 | 815,852 | Class A Common Stock |
| BeiGene Ltd - ADR | John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 254.10 per share. | 09 Jul 2025 | 10,254 | 1,553 (0%) | 0% | 254.1 | 2,605,577 | American Depositary Shares |
| Carvana Co. - Ordinary Sha... | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 348.52 per share. | 09 Jul 2025 | 10,127 | 79,312 (0%) | 0% | 348.5 | 3,529,439 | Class A Common Stock |
| Hagerty Inc - Ordinary Sha... | Robert I. Kauffman | Director | Sale of securities on an exchange or to another person at price $ 9.94 per share. | 09 Jul 2025 | 9,970 | 3,499,281 | - | 9.9 | 99,102 | Class A Common Stock |
| Carvana Co. - Ordinary Sha... | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 353.72 per share. | 09 Jul 2025 | 9,963 | 37,996 (0%) | 0% | 353.7 | 3,524,137 | Class A Common Stock |
| Marathon Digital Holdings Inc | Frederick G. Thiel | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.68 per share. | 09 Jul 2025 | 9,584 | 3,974,009 (50%) | 0% | 15.7 | 150,277 | Common Stock |
| Marathon Digital Holdings Inc | Salman H. Khan | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.70 per share. | 09 Jul 2025 | 9,433 | 1,497,261 (19%) | 0% | 15.7 | 148,098 | Common Stock |
| BeiGene Ltd - ADR | John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 253.18 per share. | 09 Jul 2025 | 9,292 | 11,807 (0%) | 0% | 253.2 | 2,352,575 | American Depositary Shares |
| Carvana Co. - Ordinary Sha... | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 352.53 per share. | 09 Jul 2025 | 9,241 | 47,959 (0%) | 0% | 352.5 | 3,257,738 | Class A Common Stock |
| Hershey | Stacy Taffet | Chief Growth Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 9,171 | 9,171 (0%) | 0% | 0 | Common Stock | |
| Carvana Co. - Ordinary Sha... | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 351.58 per share. | 09 Jul 2025 | 9,170 | 57,200 (0%) | 0% | 351.6 | 3,223,975 | Class A Common Stock |
| Carvana Co. - Ordinary Sha... | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 356.65 per share. | 09 Jul 2025 | 8,588 | 700 (0%) | 0% | 356.6 | 3,062,900 | Class A Common Stock |
| Marathon Digital Holdings Inc | Salman H. Khan | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.68 per share. | 09 Jul 2025 | 8,137 | 1,487,828 (18%) | 0% | 15.7 | 127,588 | Common Stock |
| NPK International Inc. | Lori A. Briggs | VP & President, Ind. Solutions | Sale of securities on an exchange or to another person at price $ 8.57 per share. | 09 Jul 2025 | 8,005 | 260,626 (0%) | 0% | 8.6 | 68,584 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 7,969 | 11,953 | - | - | Stock Options (Right to Buy) | |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.80 per share. | 09 Jul 2025 | 7,969 | 16,478 (0%) | 0% | 6.8 | 54,189 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 76.69 per share. | 09 Jul 2025 | 7,831 | 22,725 (0%) | 0% | 76.7 | 600,565 | Common Stock |
| Zoom Video Communications ... | Velchamy Sankarlingam | Pres. of Engineering & Product | Sale of securities on an exchange or to another person at price $ 77.50 per share. | 09 Jul 2025 | 7,661 | 129,377 (0%) | 0% | 77.5 | 593,728 | Class A Common Stock |
| Wolverine World Wide, Inc. | Jack Boyle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 7,459 | 7,459 | - | - | Restricted Stock Units | |
| Carvana Co. - Ordinary Sha... | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 346.03 per share. | 09 Jul 2025 | 7,105 | 86,835 (0%) | 0% | 346.0 | 2,458,547 | Class A Common Stock |
| Microstrategy Inc. - Ordin... | W. Ming Shao | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 420.40 per share. | 09 Jul 2025 | 7,088 | 17,189 (0%) | 0% | 420.4 | 2,979,788 | Class A Common Stock |
| Carvana Co. - Ordinary Sha... | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 347.47 per share. | 09 Jul 2025 | 7,061 | 89,439 (0%) | 0% | 347.5 | 2,453,503 | Class A Common Stock |
| Burford Capital Limited | David Perla | Vice Chair | Sale of securities on an exchange or to another person at price $ 14.60 per share. | 09 Jul 2025 | 7,000 | 80,172 | - | 14.6 | 102,165 | Ordinary shares, no par value ("Ordinary Shares") |
| Entrada Therapeutics Inc | Kush M. Parmar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 7.50 per share. | 09 Jul 2025 | 6,935 | 1,093,313 | - | 7.5 | 52,026 | Common Stock |
| Customers Bancorp Inc | Lyle P. Cunningham | Chief Banking Officer | Grant, award, or other acquisition of securities at price $ 63.97 per share. | 09 Jul 2025 | 6,893 | 55,571 (0%) | 0% | 64.0 | 440,945 | Common Stock |
| Customers Bancorp Inc | Thomas Henry Kasulka | Chief Credit Officer | Grant, award, or other acquisition of securities at price $ 63.97 per share. | 09 Jul 2025 | 6,893 | 21,808 (0%) | 0% | 64.0 | 440,945 | Common Stock |
| BeiGene Ltd - ADR | John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 252.23 per share. | 09 Jul 2025 | 6,703 | 21,099 (0%) | 0% | 252.2 | 1,690,682 | American Depositary Shares |
| Merus N.V | Peter B. Silverman | COO & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.61 per share. | 09 Jul 2025 | 6,695 | 6,695 (0%) | 0% | 18.6 | 124,594 | Common Shares |
| Merus N.V | Peter B. Silverman | COO & GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 6,695 | 16,805 | - | - | Share Option (right to buy) | |
| Merus N.V | Peter B. Silverman | COO & GC | Sale of securities on an exchange or to another person at price $ 55.00 per share. | 09 Jul 2025 | 6,695 | 0 (0%) | 0% | 55 | 368,225 | Common Shares |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.22 per share. | 09 Jul 2025 | 6,627 | 1,526,229 (8%) | 0% | 150.2 | 995,497 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.22 per share. | 09 Jul 2025 | 6,627 | 1,526,229 (8%) | 0% | 150.2 | 995,497 | Common Stock |
| Carvana Co. - Ordinary Sha... | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 350.37 per share. | 09 Jul 2025 | 6,515 | 66,370 (0%) | 0% | 350.4 | 2,282,633 | Class A Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.23 per share. | 09 Jul 2025 | 6,500 | 1,457,011 (8%) | 0% | 150.2 | 976,464 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.23 per share. | 09 Jul 2025 | 6,500 | 1,457,011 (8%) | 0% | 150.2 | 976,464 | Common Stock |
| Westamerica Bancorporation | John A. Thorson | SVP/Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 6,462 | 15,133 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Carvana Co. - Ordinary Sha... | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 349.46 per share. | 09 Jul 2025 | 6,427 | 72,885 (0%) | 0% | 349.5 | 2,245,954 | Class A Common Stock |
| Williams Companies | Todd J. Rinke | Senior Vice President | Grant, award, or other acquisition of securities at price $ 57.85 per share. | 09 Jul 2025 | 6,050 | 22,233 (0%) | 0% | 57.9 | 349,993 | Common Stock |
| Penumbra Inc | Adam Elsesser | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 243.97 per share. | 09 Jul 2025 | 5,710 | 138,546 (0%) | 0% | 244.0 | 1,393,069 | Common Stock |
| Freedom Holding Corp | Askar Tashtitov | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 5,691 | 142,899 (0%) | 0% | 0 | Common stock | |
| Williams Companies | Todd J. Rinke | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 5,643 | 5,643 | - | - | Restricted Stock Units | |
| Netsol Technologies, Inc. | Mark Caton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 5,476 | 159,550 (1%) | 0% | 0 | Common Stock | |
| Netsol Technologies, Inc. | Michael Richard Francis | Director | 09 Jul 2025 | 5,476 | 20,401 (0%) | 0% | 0 | Common Stock | ||
| Netsol Technologies, Inc. | Syed Kausar Kazmi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 5,476 | 69,413 (0%) | 0% | 0 | Common Stock | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 93.00 per share. | 09 Jul 2025 | 5,278 | 3,392 | - | 93 | 490,854 | Class A Common Stock |
| Nuvalent Inc - Ordinary Sh... | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 79.94 per share. | 09 Jul 2025 | 5,260 | 61,196 | - | 79.9 | 420,484 | Class A Common Stock |
| Procore Technologies Inc | O Kevin J Connor | Director | Sale of securities on an exchange or to another person at price $ 72.58 per share. | 09 Jul 2025 | 5,247 | 1,164,577 | - | 72.6 | 380,827 | Common Stock |
| Freedom Holding Corp | Evgeniy Ler | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 5,169 | 39,077 (0%) | 0% | 0 | Common Stock | |
| Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 5,025 | 15,075 | - | - | Stock Options (Right to Buy) | |
| Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.35 per share. | 09 Jul 2025 | 5,025 | 34,781 (0%) | 0% | 27.4 | 137,434 | Common Stock |
| CalciMedica Inc | Eric W. Roberts | Director, CHIEF BUSINESS OFFICER, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.60 per share. | 09 Jul 2025 | 5,000 | 37,823 | - | 1.6 | 8,024 | Common Stock |
| Carvana Co. - Ordinary Sha... | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 345.10 per share. | 09 Jul 2025 | 4,744 | 93,940 (0%) | 0% | 345.1 | 1,637,168 | Class A Common Stock |
| Dare Bioscience Inc | Robin J. Steele | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 4,500 | 4,500 | - | - | Stock Option (right to buy) | |
| Dare Bioscience Inc | William H. Rastetter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 4,500 | 4,500 | - | - | Stock Option (right to buy) | |
| Dare Bioscience Inc | Gregory W. Matz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 4,500 | 4,500 | - | - | Stock Option (right to buy) | |
| Dare Bioscience Inc | Susan L. Kelley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 4,500 | 4,500 | - | - | Stock Option (right to buy) | |
| Dare Bioscience Inc | Jessica D. Grossman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 4,500 | 4,500 | - | - | Stock Option (right to buy) | |
| Nuvalent Inc - Ordinary Sh... | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 4,440 | 20,859 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc - Ordinary Sh... | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.33 per share. | 09 Jul 2025 | 4,440 | 66,456 | - | 29.3 | 130,225 | Class A Common Stock |
| Procore Technologies Inc | O Kevin J Connor | Director | Sale of securities on an exchange or to another person at price $ 72.58 per share. | 09 Jul 2025 | 4,280 | 1,154,440 | - | 72.6 | 310,642 | Common Stock |
| Netsol Technologies, Inc. | Mark Caton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 4,261 | 163,811 (1%) | 0% | 0 | Common Stock | |
| Netsol Technologies, Inc. | Michael Richard Francis | Director | 09 Jul 2025 | 4,261 | 24,662 (0%) | 0% | 0 | Common Stock | ||
| Netsol Technologies, Inc. | Syed Kausar Kazmi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 4,261 | 73,674 (0%) | 0% | 0 | Common Stock | |
| Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 75.55 per share. | 09 Jul 2025 | 4,225 | 30,556 (0%) | 0% | 75.6 | 319,217 | Common Stock |
| Atlassian Corporation - Or... | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 220.13 per share. | 09 Jul 2025 | 4,205 | 448,030 (0%) | 0% | 220.1 | 925,634 | Class A Common Stock |
| Atlassian Corporation - Or... | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 220.13 per share. | 09 Jul 2025 | 4,204 | 448,031 (0%) | 0% | 220.1 | 925,414 | Class A Common Stock |
| Carvana Co. - Ordinary Sha... | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 348.01 per share. | 09 Jul 2025 | 4,170 | 79,806 (0%) | 0% | 348.0 | 1,451,200 | Class A Common Stock |
| Microstrategy Inc. - Ordin... | W. Ming Shao | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 421.43 per share. | 09 Jul 2025 | 4,045 | 13,144 (0%) | 0% | 421.4 | 1,704,696 | Class A Common Stock |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 80.00 per share. | 09 Jul 2025 | 3,985 | 8,509 (0%) | 0% | 80 | 318,800 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 75.57 per share. | 09 Jul 2025 | 3,984 | 12,494 (0%) | 0% | 75.6 | 301,051 | Common Stock |
| Greenbrier Cos., Inc. | Thomas B. Fargo | Director | Sale of securities on an exchange or to another person at price $ 54.97 per share. | 09 Jul 2025 | 3,727 | 2,141 (0%) | 0% | 55.0 | 204,855 | Common Stock |
| FedEx | Marvin R. Ellison | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 142.11 per share. | 09 Jul 2025 | 3,610 | 11,330 (0%) | 0% | 142.1 | 513,017 | Common Stock |
| FedEx | Marvin R. Ellison | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 3,610 | 0 | - | - | Stock Option (Right to Buy) | |
| FedEx | Marvin R. Ellison | Director | Sale of securities on an exchange or to another person at price $ 236.94 per share. | 09 Jul 2025 | 3,610 | 7,720 (0%) | 0% | 236.9 | 855,353 | Common Stock |
| Disc Medicine Inc | John D. Quisel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 56.20 per share. | 09 Jul 2025 | 3,593 | 161,828 | - | 56.2 | 201,925 | Common Stock |
| Penumbra Inc | Adam Elsesser | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 242.97 per share. | 09 Jul 2025 | 3,522 | 144,256 (0%) | 0% | 243.0 | 855,740 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Pamela J. Cramer | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 80.00 per share. | 09 Jul 2025 | 3,516 | 19,209 (0%) | 0% | 80 | 281,280 | Common Stock |
| Carvana Co. - Ordinary Sha... | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 346.38 per share. | 09 Jul 2025 | 3,500 | 96,500 (0%) | 0% | 346.4 | 1,212,317 | Class A Common Stock |
| Rubrik Inc. - Ordinary Sha... | Kiran Choudary | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 87.54 per share. | 09 Jul 2025 | 3,500 | 521,595 | - | 87.5 | 306,390 | Class A Common Stock |
| Kilroy Realty Corp. | Justin William Smart | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 3,490 | 373,488 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| Hercules Capital Inc | Seth H. Meyer | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.56 per share. | 09 Jul 2025 | 3,458 | 381,172 (0%) | 0% | 18.6 | 64,180 | Common Stock |
| Customers Bancorp Inc | Thomas Henry Kasulka | Chief Credit Officer | Grant, award, or other acquisition of securities at price $ 63.97 per share. | 09 Jul 2025 | 3,447 | 18,362 (0%) | 0% | 64.0 | 220,505 | Common Stock |
| Customers Bancorp Inc | Lyle P. Cunningham | Chief Banking Officer | Grant, award, or other acquisition of securities at price $ 63.97 per share. | 09 Jul 2025 | 3,447 | 52,125 (0%) | 0% | 64.0 | 220,505 | Common Stock |
| Procore Technologies Inc | O Kevin J Connor | Director | Sale of securities on an exchange or to another person at price $ 71.82 per share. | 09 Jul 2025 | 3,412 | 1,158,720 | - | 71.8 | 245,050 | Common Stock |
| Taboola.com Ltd | Eldad Maniv | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.76 per share. | 09 Jul 2025 | 3,400 | 10,819,421 | - | 3.8 | 12,784 | Ordinary Shares |
| Korn Ferry | Gary D. Burnison | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.89 per share. | 09 Jul 2025 | 3,311 | 169,807 (0%) | 0% | 74.9 | 247,961 | Common Stock, par value $0.01 per share |
| Marathon Digital Holdings Inc | Zabi Nowaid | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.68 per share. | 09 Jul 2025 | 3,254 | 812,339 (10%) | 0% | 15.7 | 51,023 | Common Stock |
| GeneDx Holdings Corp - Ord... | Katherine A. Stueland | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 93.00 per share. | 09 Jul 2025 | 3,220 | 1,720 | - | 93 | 299,460 | Class A Common Stock |
| Carvana Co. - Ordinary Sha... | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 347.02 per share. | 09 Jul 2025 | 2,859 | 83,976 (0%) | 0% | 347.0 | 992,127 | Class A Common Stock |
| Walgreens Boots Alliance | John A. Lederer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 2,590 | 108,353 | - | - | Phantom Stock Units | |
| Twist Bioscience Corp | Adam Laponis | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 38.15 per share. | 09 Jul 2025 | 2,449 | 103,569 (0%) | 0% | 38.1 | 93,420 | Common Stock |
| Procore Technologies Inc | O Kevin J Connor | Director | Sale of securities on an exchange or to another person at price $ 73.41 per share. | 09 Jul 2025 | 2,445 | 1,162,132 | - | 73.4 | 179,487 | Common Stock |
| Microstrategy Inc. - Ordin... | W. Ming Shao | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 413.81 per share. | 09 Jul 2025 | 2,426 | 29,100 (0%) | 0% | 413.8 | 1,003,915 | Class A Common Stock |
| Penumbra Inc | Adam Elsesser | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 244.71 per share. | 09 Jul 2025 | 2,379 | 136,167 (0%) | 0% | 244.7 | 582,165 | Common Stock |
| Salesforce | Marc Benioff | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 161.50 per share. | 09 Jul 2025 | 2,250 | 11,864,707 (1%) | 0% | 161.5 | 363,375 | Common Stock |
| Salesforce | Marc Benioff | Director, Chair and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 2,250 | 182,372 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Walgreens Boots Alliance | Robert Huffines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 2,158 | 29,992 | - | - | Phantom Stock Units | |
| MSC Industrial Direct Co.,... | Kimberly Shacklett | SVP, Sales & Customer Success | Exercise or conversion of derivative security received from the company (such as an option) at price $ 83.21 per share. | 09 Jul 2025 | 2,129 | 16,786 (0%) | 0% | 83.2 | 177,154 | Class A Common Stock, $0.001 par value |
| MSC Industrial Direct Co.,... | Kimberly Shacklett | SVP, Sales & Customer Success | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 2,129 | 0 | - | - | Options (right to buy) | |
| MSC Industrial Direct Co.,... | Kimberly Shacklett | SVP, Sales & Customer Success | Sale of securities on an exchange or to another person at price $ 90.60 per share. | 09 Jul 2025 | 2,129 | 14,657 (0%) | 0% | 90.6 | 192,887 | Class A Common Stock, $0.001 par value |
| Advanced Energy Industries... | John Donaghey | EVP, Global Sales | Sale of securities on an exchange or to another person at price $ 140.00 per share. | 09 Jul 2025 | 2,000 | 11,029 (0%) | 0% | 140 | 280,000 | Common Stock |
| Oxbridge Re Holdings Ltd | Allan Martin | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.22 per share. | 09 Jul 2025 | 2,000 | 104,223 (1%) | 0% | 2.2 | 4,447 | Ordinary Shares |
| Rubrik Inc. - Ordinary Sha... | Kiran Choudary | Chief Financial Officer | 09 Jul 2025 | 2,000 | 525,095 | - | 0 | Class A Common Stock | ||
| Rubrik Inc. - Ordinary Sha... | Kiran Choudary | Chief Financial Officer | 09 Jul 2025 | 2,000 | 0 | - | - | Class B Common Stock | ||
| Rubrik Inc. - Ordinary Sha... | Kiran Choudary | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 2,000 | 2,000 | - | - | Class B Common Stock | |
| Rubrik Inc. - Ordinary Sha... | Kiran Choudary | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 2,000 | 70,450 | - | - | Stock Option (Right to Buy) | |
| Rhythm Pharmaceuticals Inc. | Christopher P. German | Corporate Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 2,000 | 6,231 | - | - | Stock Options (Right to Buy) | |
| Rhythm Pharmaceuticals Inc. | Christopher P. German | Corporate Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.97 per share. | 09 Jul 2025 | 2,000 | 3,889 (0%) | 0% | 18.0 | 35,940 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Christopher P. German | Corporate Controller & CAO | Sale of securities on an exchange or to another person at price $ 76.75 per share. | 09 Jul 2025 | 1,967 | 2,772 (0%) | 0% | 76.7 | 150,967 | Common Stock |
| Nuvalent Inc - Ordinary Sh... | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 81.08 per share. | 09 Jul 2025 | 1,945 | 61,156 | - | 81.1 | 157,701 | Class A Common Stock |
| Astera Labs Inc. | Jitendra Mohan | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 102.46 per share. | 09 Jul 2025 | 1,882 | 4,339,176 | - | 102.5 | 192,831 | Common Stock |
| Astera Labs Inc. | Jitendra Mohan | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 102.46 per share. | 09 Jul 2025 | 1,880 | 509,174 | - | 102.5 | 192,626 | Common Stock |
| Astera Labs Inc. | Jitendra Mohan | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 102.46 per share. | 09 Jul 2025 | 1,880 | 509,174 | - | 102.5 | 192,626 | Common Stock |
| Astera Labs Inc. | Jitendra Mohan | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 102.46 per share. | 09 Jul 2025 | 1,880 | 759,173 | - | 102.5 | 192,626 | Common Stock |
| Astera Labs Inc. | Jitendra Mohan | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 102.46 per share. | 09 Jul 2025 | 1,880 | 759,173 | - | 102.5 | 192,626 | Common Stock |
| Astera Labs Inc. | Jitendra Mohan | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 102.46 per share. | 09 Jul 2025 | 1,880 | 759,166 | - | 102.5 | 192,626 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Christopher P. German | Corporate Controller & CAO | Sale of securities on an exchange or to another person at price $ 85.00 per share. | 09 Jul 2025 | 1,850 | 922 (0%) | 0% | 85 | 157,250 | Common Stock |
| Rhythm Pharmaceuticals Inc. | Hunter C. Smith | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 76.17 per share. | 09 Jul 2025 | 1,607 | 140,315 (0%) | 0% | 76.2 | 122,406 | Common Stock |
| BeiGene Ltd - ADR | John V. Oyler | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 254.83 per share. | 09 Jul 2025 | 1,553 | 0 (0%) | 0% | 254.8 | 395,757 | American Depositary Shares |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 17.24 per share. | 09 Jul 2025 | 1,519 | 207,724 (0%) | 0% | 17.2 | 26,188 | Common Stock |
| Rhinebeck Bancorp Inc | Kevin Nihill | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.99 per share. | 09 Jul 2025 | 1,468 | 14,532 (0%) | 0% | 12.0 | 17,601 | Common Stock |
| Penumbra Inc | Adam Elsesser | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 241.09 per share. | 09 Jul 2025 | 1,395 | 149,022 (0%) | 0% | 241.1 | 336,321 | Common Stock |
| Atlassian Corporation - Or... | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 219.28 per share. | 09 Jul 2025 | 1,350 | 446,680 (0%) | 0% | 219.3 | 296,025 | Class A Common Stock |
| Atlassian Corporation - Or... | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 219.28 per share. | 09 Jul 2025 | 1,350 | 446,681 (0%) | 0% | 219.3 | 296,025 | Class A Common Stock |
| Blackstone | Rochelle B. Lazarus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 1,334 | 57,746 (0%) | 0% | 0 | Common Stock | |
| Carvana Co. - Ordinary Sha... | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 343.92 per share. | 09 Jul 2025 | 1,316 | 98,684 (0%) | 0% | 343.9 | 452,594 | Class A Common Stock |
| Atlassian Corporation - Or... | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 221.01 per share. | 09 Jul 2025 | 1,311 | 444,570 (0%) | 0% | 221.0 | 289,740 | Class A Common Stock |
| Atlassian Corporation - Or... | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 221.01 per share. | 09 Jul 2025 | 1,310 | 444,570 (0%) | 0% | 221.0 | 289,520 | Class A Common Stock |
| Microstrategy Inc. - Ordin... | W. Ming Shao | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 417.08 per share. | 09 Jul 2025 | 1,300 | 26,000 (0%) | 0% | 417.1 | 542,198 | Class A Common Stock |
| DoorDash | Shona L. Brown | Director | Sale of securities on an exchange or to another person at price $ 244.99 per share. | 09 Jul 2025 | 1,250 | 44,302 | - | 245.0 | 306,238 | Class A Common Stock |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 1,245 | 6,228 | - | - | Employee Stock Option (Right to Buy) | |
| GeneDx Holdings Corp - Ord... | Kevin Feeley | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.67 per share. | 09 Jul 2025 | 1,245 | 8,670 | - | 32.7 | 40,674 | Class A Common Stock |
| Penumbra Inc | Adam Elsesser | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 241.96 per share. | 09 Jul 2025 | 1,244 | 147,778 (0%) | 0% | 242.0 | 300,998 | Common Stock |
| Microstrategy Inc. - Ordin... | W. Ming Shao | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 414.95 per share. | 09 Jul 2025 | 1,200 | 27,900 (0%) | 0% | 414.9 | 497,936 | Class A Common Stock |
| Microstrategy Inc. - Ordin... | W. Ming Shao | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 412.90 per share. | 09 Jul 2025 | 1,200 | 31,526 (0%) | 0% | 412.9 | 495,480 | Class A Common Stock |
| Astera Labs Inc. | Jitendra Mohan | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 100.01 per share. | 09 Jul 2025 | 1,164 | 761,053 | - | 100.0 | 116,411 | Common Stock |
| Astera Labs Inc. | Jitendra Mohan | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 100.01 per share. | 09 Jul 2025 | 1,164 | 761,053 | - | 100.0 | 116,411 | Common Stock |
| Astera Labs Inc. | Jitendra Mohan | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 100.01 per share. | 09 Jul 2025 | 1,164 | 761,046 | - | 100.0 | 116,411 | Common Stock |
| Astera Labs Inc. | Jitendra Mohan | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 100.01 per share. | 09 Jul 2025 | 1,164 | 511,054 | - | 100.0 | 116,411 | Common Stock |
| Astera Labs Inc. | Jitendra Mohan | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 100.01 per share. | 09 Jul 2025 | 1,164 | 511,054 | - | 100.0 | 116,411 | Common Stock |
| Astera Labs Inc. | Jitendra Mohan | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 100.01 per share. | 09 Jul 2025 | 1,162 | 4,341,058 | - | 100.0 | 116,211 | Common Stock |
| Immunovant Inc | Michael Geffner | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 17.24 per share. | 09 Jul 2025 | 1,160 | 224,210 (0%) | 0% | 17.2 | 19,998 | Common Stock |
| Korn Ferry | Robert P. Rozek | EVP, CFO & CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.89 per share. | 09 Jul 2025 | 1,152 | 84,501 (0%) | 0% | 74.9 | 86,273 | Common Stock, par value $0.01 per share |
| Microstrategy Inc. - Ordin... | W. Ming Shao | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 419.40 per share. | 09 Jul 2025 | 1,123 | 24,277 (0%) | 0% | 419.4 | 470,982 | Class A Common Stock |
| Penumbra Inc | Adam Elsesser | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 245.90 per share. | 09 Jul 2025 | 1,110 | 135,057 (0%) | 0% | 245.9 | 272,949 | Common Stock |
| Lithium Americas Corp | Jinhee Magie | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 1,079 | 0 | - | - | Restricted Stock Units | |
| Lithium Americas Corp | Jinhee Magie | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 1,079 | 9,079 | - | - | Common Shares | |
| FactSet Research | Gregory T. Moskoff | MD,Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 1,060 | 0 | - | - | Employee Stock Option (right to buy) | |
| FactSet Research | Gregory T. Moskoff | MD,Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 279.43 per share. | 09 Jul 2025 | 1,060 | 1,504 (0%) | 0% | 279.4 | 296,196 | Common Stock |
| FactSet Research | Gregory T. Moskoff | MD,Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 255.87 per share. | 09 Jul 2025 | 1,039 | 2,543 (0%) | 0% | 255.9 | 265,849 | Common Stock |
| FactSet Research | Gregory T. Moskoff | MD,Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 1,039 | 0 | - | - | Employee Stock Option (right to buy) | |
| Smith & Nephew plc - ADR | Deepak S. Nath | Executive Director,Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 14.89 per share. | 09 Jul 2025 | 1,025 | 270,412 (0%) | 0% | 14.9 | 15,259 | Ords 0.20p |
| FactSet Research | Gregory T. Moskoff | MD,Controller and CAO | Sale of securities on an exchange or to another person at price $ 443.80 per share. | 09 Jul 2025 | 1,024 | 141 (0%) | 0% | 443.8 | 454,451 | Common Stock |
| Kayne Anderson Energy Infr... | Michael J. O'Neil | Executive VP & Secretary | Purchase of securities on an exchange or from another person at price $ 12.43 per share. | 09 Jul 2025 | 1,000 | 9,390 (0%) | 0% | 12.4 | 12,430 | Common Stock |
| Oxbridge Re Holdings Ltd | Allan Martin | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.06 per share. | 09 Jul 2025 | 1,000 | 106,223 (1%) | 0% | 2.1 | 2,065 | Ordinary Shares |
| Tractor Supply | Denise L. Jackson | Director | Sale of securities on an exchange or to another person at price $ 57.00 per share. | 09 Jul 2025 | 1,000 | 34,288 (0%) | 0% | 57 | 57,000 | Common stock |
| Hercules Capital Inc | Christian Follmann | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.56 per share. | 09 Jul 2025 | 960 | 120,252 (0%) | 0% | 18.6 | 17,818 | Common Stock |
| Hercules Capital Inc | Kiersten Zaza Botelho | Chief Legal Officer & CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.56 per share. | 09 Jul 2025 | 912 | 66,651 (0%) | 0% | 18.6 | 16,927 | Common Stock |
| Nuvalent Inc - Ordinary Sh... | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 878 | 27,450 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc - Ordinary Sh... | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.85 per share. | 09 Jul 2025 | 878 | 62,016 | - | 27.8 | 24,452 | Class A Common Stock |
| Salesforce | Marc Benioff | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 271.07 per share. | 09 Jul 2025 | 855 | 11,863,168 (1%) | 0% | 271.1 | 231,769 | Common Stock |
| J.Jill Inc | Mary Ellen Coyne | Director, CEO & President | Other type of transaction at price $ 0.00 per share. | 09 Jul 2025 | 851 | 164,348 (0%) | 0% | 0 | Common Stock | |
| Rhythm Pharmaceuticals Inc. | Christopher P. German | Corporate Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 850 | 4,550 | - | - | Stock Options (Right to Buy) | |
| Rhythm Pharmaceuticals Inc. | Christopher P. German | Corporate Controller & CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 49.23 per share. | 09 Jul 2025 | 850 | 4,739 (0%) | 0% | 49.2 | 41,846 | Common Stock |
| Agios Pharmaceuticals Inc | Sarah Gheuens | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 38.76 per share. | 09 Jul 2025 | 847 | 61,271 (0%) | 0% | 38.8 | 32,830 | Common stock |
| Palantir | Lauren Elaina Friedman Stat | Director | Sale of securities on an exchange or to another person at price $ 139.61 per share. | 09 Jul 2025 | 800 | 62,887 | - | 139.6 | 111,688 | Class A Common Stock |
| Kilroy Realty Corp. | Angela M. Aman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 744 | 110,965 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| Kilroy Realty Corp. | Heidi R. Roth | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 743 | 72,710 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| Kilroy Realty Corp. | Justin William Smart | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 724 | 93,284 | - | - | Restricted Stock Units | |
| Atlassian Corporation - Or... | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 218.29 per share. | 09 Jul 2025 | 700 | 445,980 (0%) | 0% | 218.3 | 152,804 | Class A Common Stock |
| Atlassian Corporation - Or... | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 218.29 per share. | 09 Jul 2025 | 700 | 445,981 (0%) | 0% | 218.3 | 152,804 | Class A Common Stock |
| Carvana Co. - Ordinary Sha... | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 357.21 per share. | 09 Jul 2025 | 700 | 0 (0%) | 0% | 357.2 | 250,048 | Class A Common Stock |
| Kilroy Realty Corp. | Justin William Smart | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 685 | 93,970 | - | - | Restricted Stock Units | |
| Salesforce | Marc Benioff | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 270.26 per share. | 09 Jul 2025 | 684 | 11,864,023 (1%) | 0% | 270.3 | 184,861 | Common Stock |
| Microstrategy Inc. - Ordin... | W. Ming Shao | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 418.34 per share. | 09 Jul 2025 | 600 | 25,400 (0%) | 0% | 418.3 | 251,001 | Class A Common Stock |
| Microstrategy Inc. - Ordin... | W. Ming Shao | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 415.95 per share. | 09 Jul 2025 | 600 | 27,300 (0%) | 0% | 415.9 | 249,569 | Class A Common Stock |
| FactSet Research | Gregory T. Moskoff | MD,Controller and CAO | Sale of securities on an exchange or to another person at price $ 442.54 per share. | 09 Jul 2025 | 591 | 1,165 (0%) | 0% | 442.5 | 261,541 | Common Stock |
| Arrow Financial Corp. | Elizabeth A. Miller | Director | Other type of transaction at price $ 27.47 per share. | 09 Jul 2025 | 569 | 38,380 (0%) | 0% | 27.5 | 15,630 | Common Stock |
| J.Jill Inc | Mark W. Webb | EVP, CFO & COO | Other type of transaction at price $ 0.00 per share. | 09 Jul 2025 | 549 | 178,055 (0%) | 0% | 0 | Common Stock | |
| Kilroy Realty Corp. | Gary R. Stevenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 549 | 36,644 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| Kilroy Realty Corp. | Angela M. Aman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 537 | 35,837 | - | - | Restricted Stock Units | |
| Arrow Financial Corp. | James M. Dawsey | Director | Other type of transaction at price $ 27.47 per share. | 09 Jul 2025 | 501 | 17,763 (0%) | 0% | 27.5 | 13,762 | Common Stock |
| Prosperity Bancshares Inc. | Ned S. Holmes | Director | Sale of securities on an exchange or to another person at price $ 74.13 per share. | 09 Jul 2025 | 500 | 97,915 (0%) | 0% | 74.1 | 37,064 | Common Stock |
| Prosperity Bancshares Inc. | Ned S. Holmes | Director | Sale of securities on an exchange or to another person at price $ 74.11 per share. | 09 Jul 2025 | 500 | 115,193 (0%) | 0% | 74.1 | 37,055 | Common Stock |
| Oxbridge Re Holdings Ltd | Allan Martin | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.11 per share. | 09 Jul 2025 | 500 | 107,223 (1%) | 0% | 2.1 | 1,057 | Ordinary Shares |
| Oxbridge Re Holdings Ltd | Allan Martin | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.06 per share. | 09 Jul 2025 | 500 | 239,131 (4%) | 0% | 2.1 | 1,030 | Ordinary Shares |
| FactSet Research | Gregory T. Moskoff | MD,Controller and CAO | Sale of securities on an exchange or to another person at price $ 440.56 per share. | 09 Jul 2025 | 491 | 2,052 (0%) | 0% | 440.6 | 216,315 | Common Stock |
| Penumbra Inc | Adam Elsesser | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 247.92 per share. | 09 Jul 2025 | 450 | 134,607 (0%) | 0% | 247.9 | 111,564 | Common Stock |
| Kilroy Realty Corp. | A. Robert Paratte | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 447 | 57,667 | - | - | Restricted Stock Units | |
| Kilroy Realty Corp. | A. Robert Paratte | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 423 | 58,091 | - | - | Restricted Stock Units | |
| Microstrategy Inc. - Ordin... | W. Ming Shao | EVP & General Counsel | Sale of securities on an exchange or to another person at price $ 422.14 per share. | 09 Jul 2025 | 418 | 12,726 (0%) | 0% | 422.1 | 176,453 | Class A Common Stock |
| Arrow Financial Corp. | Tenee Rehm Casaccio | Director | Other type of transaction at price $ 27.47 per share. | 09 Jul 2025 | 410 | 25,897 (0%) | 0% | 27.5 | 11,263 | Common Stock |
| Kilroy Realty Corp. | Jeffrey Kuehling | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 408 | 27,206 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| FactSet Research | Gregory T. Moskoff | MD,Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 316.71 per share. | 09 Jul 2025 | 401 | 444 (0%) | 0% | 316.7 | 127,001 | Common Stock |
| FactSet Research | Gregory T. Moskoff | MD,Controller and CAO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 401 | 622 | - | - | Employee Stock Option (right to buy) | |
| Kilroy Realty Corp. | Edward F. Brennan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 386 | 38,144 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| Kilroy Realty Corp. | A. Robert Paratte | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 384 | 87,560 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| Korn Ferry | Michael DiStefano | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 74.89 per share. | 09 Jul 2025 | 369 | 50,921 (0%) | 0% | 74.9 | 27,634 | Common Stock, par value $0.01 |
| Five Star Bancorp | Shelley R. Wetton | SVP & Chief Marketing Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Jul 2025 | 352 | 23,806 | - | 0 | Common Stock | |
| Kilroy Realty Corp. | Eliott Trencher | EVP, Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 347 | 42,812 | - | - | Restricted Stock Units | |
| Procore Technologies Inc | O Kevin J Connor | Director | Sale of securities on an exchange or to another person at price $ 75.03 per share. | 09 Jul 2025 | 343 | 1,154,097 | - | 75.0 | 25,735 | Common Stock |
| General Mills | Jacqueline Williams-Roll | Chief Human Resources Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Jul 2025 | 337 | 49,164 (0%) | 0% | 0 | Common Stock | |
| General Mills | Jacqueline Williams-Roll | Chief Human Resources Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Jul 2025 | 337 | 70,592 (0%) | 0% | 0 | Common Stock | |
| Kilroy Realty Corp. | Peter B. Stoneberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 335 | 33,985 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| Carvana Co. - Ordinary Sha... | Ernest C. Garcia | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 353.74 per share. | 09 Jul 2025 | 325 | 0 (0%) | 0% | 353.7 | 114,966 | Class A Common Stock |
| Arrow Financial Corp. | David G. Kruczlnicki | Director | Other type of transaction at price $ 27.47 per share. | 09 Jul 2025 | 307 | 58,839 (0%) | 0% | 27.5 | 8,433 | Common Stock |
| Arrow Financial Corp. | Colin L. Read | Director | Other type of transaction at price $ 27.47 per share. | 09 Jul 2025 | 307 | 29,099 (0%) | 0% | 27.5 | 8,433 | Common Stock |
| Arrow Financial Corp. | Gregory J. Champion | Director | Other type of transaction at price $ 27.47 per share. | 09 Jul 2025 | 307 | 9,686 (0%) | 0% | 27.5 | 8,433 | Common Stock |
| Kilroy Realty Corp. | Louisa G. Ritter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 303 | 22,823 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| Kilroy Realty Corp. | Merryl E. Werber | SVP, CAO, Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 301 | 32,684 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 151.39 per share. | 09 Jul 2025 | 300 | 1,456,711 (8%) | 0% | 151.4 | 45,416 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 151.39 per share. | 09 Jul 2025 | 300 | 1,525,929 (8%) | 0% | 151.4 | 45,416 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 151.39 per share. | 09 Jul 2025 | 300 | 1,525,929 (8%) | 0% | 151.4 | 45,416 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 151.39 per share. | 09 Jul 2025 | 300 | 1,456,711 (8%) | 0% | 151.4 | 45,416 | Common Stock |
| Kilroy Realty Corp. | Eliott Trencher | EVP, Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 299 | 43,111 | - | - | Restricted Stock Units | |
| FactSet Research | Gregory T. Moskoff | MD,Controller and CAO | Sale of securities on an exchange or to another person at price $ 441.36 per share. | 09 Jul 2025 | 296 | 1,756 (0%) | 0% | 441.4 | 130,643 | Common Stock |
| Kilroy Realty Corp. | Eliott Trencher | EVP, Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 293 | 47,822 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| Rexford Industrial Realty Inc | Howard Schwimmer | Director, Co-CEO, Co-President | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Jul 2025 | 290 | 45,387 | - | - | Operating Partnership Units | |
| Arrow Financial Corp. | Mark L. Behan | Director | Other type of transaction at price $ 27.47 per share. | 09 Jul 2025 | 284 | 11,417 (0%) | 0% | 27.5 | 7,801 | Common Stock |
| Arrow Financial Corp. | Kristine D. Duffy | Director | Other type of transaction at price $ 27.47 per share. | 09 Jul 2025 | 284 | 4,855 (0%) | 0% | 27.5 | 7,801 | Common Stock |
| Kilroy Realty Corp. | Heidi R. Roth | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 263 | 33,922 | - | - | Restricted Stock Units | |
| Arrow Financial Corp. | Daniel James White | Director | Other type of transaction at price $ 27.47 per share. | 09 Jul 2025 | 262 | 4,897 (0%) | 0% | 27.5 | 7,197 | Common Stock |
| Arrow Financial Corp. | Oconor F Raymond | Director | Other type of transaction at price $ 27.47 per share. | 09 Jul 2025 | 250 | 29,543 (0%) | 0% | 27.5 | 6,868 | Common Stock |
| Arrow Financial Corp. | Philip C. Morris | Director | Other type of transaction at price $ 27.47 per share. | 09 Jul 2025 | 250 | 5,712 (0%) | 0% | 27.5 | 6,868 | Common Stock |
| Salesforce | Marc Benioff | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 274.53 per share. | 09 Jul 2025 | 250 | 11,862,572 (1%) | 0% | 274.5 | 68,633 | Common Stock |
| Kilroy Realty Corp. | Heidi R. Roth | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 249 | 34,171 | - | - | Restricted Stock Units | |
| Nuvalent Inc - Ordinary Sh... | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 80.92 per share. | 09 Jul 2025 | 240 | 60,956 | - | 80.9 | 19,421 | Class A Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.14 per share. | 09 Jul 2025 | 200 | 1,463,511 (8%) | 0% | 150.1 | 30,028 | Common Stock |
| Krystal Biotech Inc | Krish S. Krishnan | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.07 per share. | 09 Jul 2025 | 200 | 1,532,856 (8%) | 0% | 150.1 | 30,014 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.07 per share. | 09 Jul 2025 | 200 | 1,532,856 (8%) | 0% | 150.1 | 30,014 | Common Stock |
| Krystal Biotech Inc | Suma M. Krishnan | Director, President, R&D, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.14 per share. | 09 Jul 2025 | 200 | 1,463,511 (8%) | 0% | 150.1 | 30,028 | Common Stock |
| Nuvalent Inc - Ordinary Sh... | Henry E. Pelish | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 81.90 per share. | 09 Jul 2025 | 200 | 60,956 | - | 81.9 | 16,380 | Class A Common Stock |
| J.Jill Inc | Maria D. Martinez | See Remarks | Other type of transaction at price $ 0.00 per share. | 09 Jul 2025 | 192 | 40,154 (0%) | 0% | 0 | Common Stock | |
| Kilroy Realty Corp. | Daryl J. Carter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 185 | 12,356 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| Nuvalent Inc - Ordinary Sh... | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2025 | 182 | 18,099 | - | - | Stock Option (Right to Buy) | |
| Nuvalent Inc - Ordinary Sh... | Henry E. Pelish | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.93 per share. | 09 Jul 2025 | 182 | 61,138 | - | 18.9 | 3,445 | Class A Common Stock |
| Salesforce | Marc Benioff | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 273.53 per share. | 09 Jul 2025 | 178 | 11,862,822 (1%) | 0% | 273.5 | 48,689 | Common Stock |
| Penumbra Inc | Adam Elsesser | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 248.79 per share. | 09 Jul 2025 | 175 | 134,432 (0%) | 0% | 248.8 | 43,538 | Common Stock |
| Salesforce | Marc Benioff | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 272.16 per share. | 09 Jul 2025 | 168 | 11,863,000 (1%) | 0% | 272.2 | 45,723 | Common Stock |
| Kilroy Realty Corp. | Lauren N Stadler | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 167 | 15,800 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| J.Jill Inc | Mark W. Webb | EVP, CFO & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 139 | 29,592 | - | - | Performance Stock Units | |
| Salesforce | Marc Benioff | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 275.08 per share. | 09 Jul 2025 | 115 | 11,862,457 (1%) | 0% | 275.1 | 31,634 | Common Stock |
| Prosperity Bancshares Inc. | Ned S. Holmes | Director | Sale of securities on an exchange or to another person at price $ 74.15 per share. | 09 Jul 2025 | 100 | 45,000 (0%) | 0% | 74.2 | 7,415 | Common Stock |
| Atlassian Corporation - Or... | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 221.92 per share. | 09 Jul 2025 | 100 | 445,880 (0%) | 0% | 221.9 | 22,192 | Class A Common Stock |
| Atlassian Corporation - Or... | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 221.92 per share. | 09 Jul 2025 | 100 | 445,881 (0%) | 0% | 221.9 | 22,192 | Class A Common Stock |
| FactSet Research | Gregory T. Moskoff | MD,Controller and CAO | Sale of securities on an exchange or to another person at price $ 444.48 per share. | 09 Jul 2025 | 98 | 43 (0%) | 0% | 444.5 | 43,559 | Common Stock |
| Dine Brands Global Inc | Douglas M. Pasquale | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 95 | 4,827 | - | - | Restricted Stock Units (Dividend Equivalent Rights) | |
| Dine Brands Global Inc | Howard M. Berk | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 95 | 4,827 | - | - | Restricted Stock Units (Dividend Equivalent Rights) | |
| Dine Brands Global Inc | Richard J. Dahl | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 95 | 4,827 | - | - | Restricted Stock Units (Dividend Equivalent Rights) | |
| Dine Brands Global Inc | Martha C. Poulter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 95 | 4,827 | - | - | Restricted Stock Units (Dividend Equivalent Rights) | |
| Dine Brands Global Inc | Lilian C. Tomovich | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 95 | 4,827 | - | - | Restricted Stock Units (Dividend Equivalent Rights) | |
| Dine Brands Global Inc | Arthur Francis Starrs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 95 | 4,827 | - | - | Restricted Stock Units (Dividend Equivalent Rights) | |
| Dine Brands Global Inc | Michael C. Hyter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 95 | 4,827 | - | - | Restricted Stock Units (Dividend Equivalent Rights) | |
| Dine Brands Global Inc | Matthew T. Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 95 | 4,827 | - | - | Restricted Stock Units (Dividend Equivalent Rights) | |
| J.Jill Inc | Elliot Staples | See Remarks | Other type of transaction at price $ 0.00 per share. | 09 Jul 2025 | 77 | 21,677 (0%) | 0% | 0 | Common Stock | |
| J.Jill Inc | Mary Ellen Coyne | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 77 | 14,940 | - | - | Performance Stock Units | |
| Kilroy Realty Corp. | Jolie A. Hunt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2025 | 67 | 25,143 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| Commercial Metals Co. | Sarah E. Raiss | Director | Grant, award, or other acquisition of securities at price $ 52.45 per share. | 09 Jul 2025 | 56 | 100,499 (0%) | 0% | 52.4 | 2,937 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.